Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acne Vulgaris Prevention
Researchers from Tokyo Women's Medical University, Department of Dermatology publish findings in acne vulgaris prevention
April 6th, 2008
Researchers detail in 'Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study,' new data in acne vulgaris. According to recent research published in the Journal of Dermatological Science, "Topical retinoids, such as adapalene, are an integral part of acne therapy in most regions and are considered appropriate first-line therapy by international guidelines for all cases of acne with the exception of the most severe. However, there are currently no topical retinoids available for the treatment of acne vulgaris in Japan." "To confirm efficacy and safety of adapalene gel...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
